Cart is empty A research team co-led by scientists at the University of Arizona College of Medicine—Tucson found that an osteoporosis drug might counter a rare genetic mutation underlying a type of heart disease. The results were published today in the Journal of Clinical Investigation and could have implications for treating other rare diseases.
Leave A Comment